Monday, January 2, 2017

BRIEF-Serodus says primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy

* Says primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)